128 related articles for article (PubMed ID: 4942414)
1. The metabolism and pharmacology of 5-fluorouracil.
Miller E
J Surg Oncol; 1971; 3(3):309-15. PubMed ID: 4942414
[No Abstract] [Full Text] [Related]
2. Combination chemotherapy in gastrointestinal cancer.
Reitemeier RJ; Moertel CG; Hahn RG
Cancer Res; 1970 May; 30(5):1425-8. PubMed ID: 4246651
[No Abstract] [Full Text] [Related]
3. A controlled evaluation of 5-fluorouracil utilizing a single injection technique.
Ahmann DL; Moertel CG; Bisel HF; Hahn RG; Schutt AJ; Dines DE
Oncology; 1974; 29(2):166-71. PubMed ID: 4836677
[No Abstract] [Full Text] [Related]
4. Mechanism of potentiation of antitumor activity of 5-fluorouracil against adenocarcinoma 755 by L-cysteine.
Iigo M; Hoshi A
Biochem Pharmacol; 1986 Mar; 35(5):727-30. PubMed ID: 3954782
[No Abstract] [Full Text] [Related]
5. The effect of 5-fluorouracil on small bowel mucosa.
White RS; Fuqua WB; Barrett O
J Surg Oncol; 1971; 3(5):501-6. PubMed ID: 5114102
[No Abstract] [Full Text] [Related]
6. Clinical pharmacology of oral and intravenous 5-fluorouracil (NSC-19893).
Cohen JL; Irwin LE; Marshall GJ; Darvey H; Bateman JR
Cancer Chemother Rep; 1974; 58(5 Pt 1):723-31. PubMed ID: 4609602
[No Abstract] [Full Text] [Related]
7. Oral administration of fluorouracil. A preliminary trial.
Nadler SH
Arch Surg; 1968 Oct; 97(4):654-6. PubMed ID: 5678137
[No Abstract] [Full Text] [Related]
8. Modulation of 5-fluorouracil toxicity by uridine, deoxyuridine, orotate and dipyridamole in normal tissues of rats with liver adenocarcinoma.
el Hag IA; Jakobsson B; Christensson PI; Erichsen C; Jönsson PE; Stenram U
In Vivo; 1987; 1(5):309-12. PubMed ID: 2485133
[TBL] [Abstract][Full Text] [Related]
9. Toxicity studies of fluorouracil used with adrenalectomy in breast cancer.
Piro AJ; Wilson RE; Hall TC; Aliapoulios MA; Nevinny HB; Moore FD
Arch Surg; 1972 Jul; 105(1):95-9. PubMed ID: 5031606
[No Abstract] [Full Text] [Related]
10. On the action of fluorouracil on leukemia cells.
Goldberg AR; Machledt JH; Pardee AB
Cancer Res; 1966 Aug; 26(8):1611-5. PubMed ID: 5923159
[No Abstract] [Full Text] [Related]
11. The clinical pharmacology of antineoplastic agents (first of two parts).
Chabner BA; Myers CE; Coleman CN; Johns DG
N Engl J Med; 1975 May; 292(21):1107-13. PubMed ID: 124015
[No Abstract] [Full Text] [Related]
12. The administration of 5-fluorouracil by mouth.
Bruckner HW; Creasey WA
Cancer; 1974 Jan; 33(1):14-8. PubMed ID: 4810089
[No Abstract] [Full Text] [Related]
13. [Fluorouracil for advanced breast cancer].
Solheim OP
Tidsskr Nor Laegeforen; 1974 Jan; 94(2):69-71. PubMed ID: 4822268
[No Abstract] [Full Text] [Related]
14. [Comparative in vitro studies with 5-fluorouracil and some of its derivatives].
Weitzel G; Warnecke P; Seeber S
Hoppe Seylers Z Physiol Chem; 1969 Jun; 350(6):734-40. PubMed ID: 4240568
[No Abstract] [Full Text] [Related]
15. Kinetic alterations induced by 5-fluorouracil in bone marrow, intestinal mucosa, and tumor.
Myers CE; Young RC; Chabner BA
Cancer Res; 1976 May; 36(5):1653-8. PubMed ID: 1268826
[TBL] [Abstract][Full Text] [Related]
16. Effect of 5-fluorouracil and actinomycin D on repair of DNA single-strand breaks in cervix cancer cells.
Byfield JE; Lee YC
J Natl Cancer Inst; 1973 Feb; 50(2):573-5. PubMed ID: 4735679
[No Abstract] [Full Text] [Related]
17. Topical therapy with 5-Fluorouracil.
Jansen GT
J Surg Oncol; 1971; 3(3):317-23. PubMed ID: 5110336
[No Abstract] [Full Text] [Related]
18. Treatment of cancer with weekly intravenous 5-fluorouracil. Study by the Western Cooperative Cancer Chemotherapy Group (WCCCG).
Jacobs EM; Reeves WJ; Wood DA; Pugh R; Braunwald J; Bateman JR
Cancer; 1971 Jun; 27(6):1302-5. PubMed ID: 5088208
[No Abstract] [Full Text] [Related]
19. Dihydropyrimidine dehydrogenase activity: prognostic partner of 5-fluorouracil?
Allegra CJ
Clin Cancer Res; 1999 Aug; 5(8):1947-9. PubMed ID: 10473070
[No Abstract] [Full Text] [Related]
20. [Partial synchronization of proliferative cell cycle following administration of cytostatics and followed by radiotherapy in the treatment of inoperable skin neoplasms].
Kik A
Przegl Dermatol; 1976; 63(1):87-93. PubMed ID: 56764
[No Abstract] [Full Text] [Related]
[Next] [New Search]
